68 related articles for article (PubMed ID: 2826376)
1. Potential limitation of growth-inhibitory action of recombinant human tumor necrosis factor (PAC-4D) due to easy induction of resistance: evidence in vitro.
Hanada M; Shimoyama M
Jpn J Cancer Res; 1987 Nov; 78(11):1266-73. PubMed ID: 2826376
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent cytotoxic action of human recombinant alpha-interferon (Ro22-8181) in vitro and the sensitivity of various cultured leukemia and lymphoma cell lines to it.
Shibata T; Shimada Y; Shimoyama M
Jpn J Clin Oncol; 1985 Mar; 15(1):67-75. PubMed ID: 3981816
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of quinocarmycin (KW2152) against various cultured leukemia and lymphoma cell lines in vitro.
Inaba S; Shimoyama M
Cancer Res; 1988 Nov; 48(21):6029-32. PubMed ID: 3167853
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
5. Influence of fetal calf serum on growth-inhibitory activity of human recombinant gamma-interferon (GI-3) in vitro.
Hanada M; Shimoyama M
Jpn J Cancer Res; 1986 Nov; 77(11):1153-60. PubMed ID: 3098725
[TBL] [Abstract][Full Text] [Related]
6. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells.
Matsuda M; Masutani H; Nakamura H; Miyajima S; Yamauchi A; Yonehara S; Uchida A; Irimajiri K; Horiuchi A; Yodoi J
J Immunol; 1991 Dec; 147(11):3837-41. PubMed ID: 1719091
[TBL] [Abstract][Full Text] [Related]
7. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha.
Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R
Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effects of the tumor necrosis factor (PAC-4D) against human gynecological carcinoma transplanted into nude mice].
Suzumori K; Yasui Y; Yagami Y; Kimura K
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2341-6. PubMed ID: 3606153
[TBL] [Abstract][Full Text] [Related]
9. In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivity.
Hong WS; Saijo N; Sasaki Y; Shinkai T; Eguchi K; Sakurai M; Takahashi H; Nakano H; Nakagawa K; Twentyman PR
Jpn J Cancer Res; 1987 Nov; 78(11):1274-80. PubMed ID: 3121562
[TBL] [Abstract][Full Text] [Related]
10. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
11. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation.
Hu X; Tang M; Fisher AB; Olashaw N; Zuckerman KS
J Immunol; 1999 Sep; 163(6):3106-15. PubMed ID: 10477576
[TBL] [Abstract][Full Text] [Related]
12. Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.
Zimmerman RJ; Chan A; Leadon SA
Cancer Res; 1989 Apr; 49(7):1644-8. PubMed ID: 2924312
[TBL] [Abstract][Full Text] [Related]
13. Endonuclease activity and induction of DNA fragmentation in human myelogenous leukemic cell lines.
Yanagisawa-Shiota F; Sakagami H; Kuribayashi N; Iida M; Sakagami T; Takeda M
Anticancer Res; 1995; 15(2):259-65. PubMed ID: 7762992
[TBL] [Abstract][Full Text] [Related]
14. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
15. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
Pollack IF; Erff M; Ashkenazi A
Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines.
Munker M; Munker R; Saxton RE; Koeffler HP
Cancer Res; 1987 Aug; 47(15):4081-5. PubMed ID: 3038306
[TBL] [Abstract][Full Text] [Related]
17. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
[TBL] [Abstract][Full Text] [Related]
18. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
19. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma.
Ruggiero V; Tavernier J; Fiers W; Baglioni C
J Immunol; 1986 Apr; 136(7):2445-50. PubMed ID: 3005411
[TBL] [Abstract][Full Text] [Related]
20. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
